Submit News | Submit Press Releases | Create Profile | News Pricing | Become an Affiliate | RSS | Alerts | WooEB    
Business News

Vermillion (PKS: VRMLQ) Files Plan of Reorganization

Ft. Lauderdale 11/25/2009 08:40 PM GMT (TransWorldNews)

 

Vermillion, Inc. (Pink Sheets: VRMLQ) stated it filed its Plan of Reorganization and Disclosure Statement  recently filed November 24, 2009, with the United States Bankruptcy Court for the District of Delaware. A hearing to consider approval of the Disclosure Statement is presently scheduled for December 8, 2009, with the hearing on the confirmation of the Plan scheduled for January 7, 2010.

 

Try Best Penny Stocks, a web based financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter

 

The Plan calls for Vermillion to pay all claims in full. The Plan is expected, if approved, to allow holders of the Vermillion's common stock to retain their equity interests in  Vermillion.  Gail S. Page, Executive Chairperson of  Board of Directors of Vermillion said, "With the support of our equity holders and major creditor constituencies, we are looking forward to our expeditious emergence from Chapter 11 as a healthier and stronger company. A confirmed plan will ensure that we are able to focus on our launch of the OVA1(TM) Test, the first FDA-cleared blood test that, prior to surgery, can help physicians determine if a woman is at risk for a malignant pelvic mass." OVA1 is the first FDA-cleared laboratory test that can indicate the likelihood of ovarian cancer with high sensitivity prior to biopsy or exploratory surgery, even if radiological test results fail to indicate malignancy. "OVA-1, which we anticipate will ultimately improve survival rates among women afflicted with ovarian cancer," said Page.  Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, hematology, cardiology and women's health. Vermillion is based in Fremont, California.

 

Sign up for the Try Best Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.

 

About Us

 

Try Best Penny Stocks is a financial web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.

 

Please click here to read the full disclaimer

 

staff@trybestpennystocks.com
www.trybestpennystocks.com

Empty Image

Empty Image

   |    View Profile

Visit Blogs                           |    Bookmark and Share

Empty Image

NEWS ALERTS

Receive alerts for Try Best Penny Stocks to your inbox. Sign up for TransWorldNews Alerts

Empty Image